BIOMIN, a.s.
ActiveKey figures
Key figures
2025Dividends
calculatedDistributed as dividends 41 183 € (5 % of distributable profit).
In addition, equity decreased by 157 658 € other than from retained earnings — e.g. a share capital reduction, a payout from other funds or a revaluation. The open data does not show whether this was a payout to shareholders.
Summary: BIOMIN, a.s.
What kind of company is it?
BIOMIN, a.s. (IČO 00681725) is a joint-stock company (a.s.). The company was incorporated in 1990 and has existed for 36 years. Registered office according to the register: Cífer. Main activity according to the Statistical Office: výroba farmaceutických prípravkov (SK NACE 2120). Size category by number of employees: 25–49 employees.
Who runs the company and who owns it?
The statutory body has 3 members. The supervisory board has 3 members. The registered capital is 585 000 €.
How is the company doing financially?
Revenue for 2025 was 6 992 784 €, up 33,2 % on the previous year (5 248 584 €). From 2020 to 2025, revenue grew by an average of 16,5 % per year. This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 807 260 € (11,5 % of revenue). The company was profitable in all 6 reported years. Personnel costs for 2025 were 1 010 460 €. At the end of 2025 the company had total assets of 5 566 815 € and equity of 3 628 381 € (equity ratio 65,2 %).
Where does the data come from and how current is it?
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 22. 11. 2026. The LEI code (097900CAKA0000143244) comes from the GLEIF database. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.
Summary of annual reports2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 4 622 803 | 3 636 807 | 4 331 142 | 5 248 584 | 6 992 784 |
| Profit for the reporting year | 327 889 | 226 195 | 114 087 | 173 422 | 807 260 |
| Retained earnings of previous periods | 130 382 | 410 480 | 599 018 | 679 305 | 811 544 |
| Total assets | 5 229 782 | 5 500 212 | 5 078 616 | 5 020 723 | 5 566 815 |
| Total liabilities | 1 920 603 | 2 008 492 | 1 577 099 | 1 406 144 | 1 428 975 |
| Total equity | 2 658 298 | 2 869 490 | 2 968 540 | 3 019 962 | 3 628 381 |
| Calculated dividends | 9 950 | 15 003 | 15 037 | 33 800 | 41 183 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
The graph is based on entries in the Register of Legal Persons. Shares are calculated from shareholders' contributions; this is not a record of beneficial owners. Individuals are not linked across companies.
Documents in the Register of Financial Statements12
- 2025 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2025 Úč POD · 12 pp.
- 2025 Úč POD
- 2024 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2024 Úč POD · 12 pp.
- 2024 Úč POD
- 2023 Úč POD · 12 pp.
- 2023 Úč POD
- 2022 Úč POD · 12 pp.
- 2022 Úč POD
- 2021 Úč POD · 12 pp.
- 2021 Úč POD
Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).
Similar companies
- Vitalos s. r. o. · Bratislava
- UNIMED PHARMA, spol. s r.o. · Bratislava
- HBM Pharma s.r.o. · Martin
- G.V.Pharma, a.s. · Hlohovec
- Pharmagal, spol. s.r.o. · Nitra
- hameln rds s. r. o. · Modra
- BEL - MIDITECH, s.r.o. · Kráľová pri Senci
- MED-PLANT, s.r.o. · Modra
- VALOVIČ, s.r.o. · Bratislava
- GALVEX, spol. s r.o. · Banská Bystrica